MS: Busting the Myths
May 15, 2024 | Advocacy, Funding, Life with MS, Media, News, Press Release, Treatments
A celebrated Pharmac decision late last year to fund a vital drug for many Multiple Sclerosis patients has fallen flat – with dozens being turned away for treatment due to severely stretched resources across a number of services. Multiple Sclerosis […]
February 29, 2024 | Advocacy, Treatments
Pharmac announced, in February, it was looking to extend funded access to Shingrix, the new vaccination for shingles, to immunocompromised people over 18 years old. However, the proposal listed specific treatments and conditions eligible. While we were pleased to see […]
February 29, 2024 | Treatments
In December 2023, Pharmac proposed to decline funding for inactive applications, this included an application to fund Sativex for MS spasticity. MSNZ has written to the Pharmac Board to ask that this application remain live and we be permitted to […]
January 31, 2024 | Education, Life with MS, Progressive, Support, Symptoms, Training, Treatments
We are thrilled to share with you our newest resources. Our Living Well with MS (LWWMS) booklet will provide you with a good overview of what multiple sclerosis is, what causes it, how it is diagnosed, the symptoms and treatment […]
December 20, 2023 | Advocacy, Life with MS, Treatments
On the 1st of October Ocrevus (Ocrelizumab) was finally funded for those with Primary Progressive MS (PPMS) who meet the Pharmac criteria for access. We prepared some information to answer the most common questions we have been receiving. Ocrevus for […]